AOD-9604
AOD-9604 is a modified fragment of human growth hormone (hGH fragment 177-191) with an additional tyrosine residue. It was developed to isolate the metabolic activity of growth hormone from its growth-promoting effects.
Mechanism of Action
Research suggests AOD-9604 may stimulate lipolysis and inhibit lipogenesis without affecting IGF-1 levels or insulin sensitivity. It is believed to interact with the beta-3 adrenergic receptor pathway.
Research Background
AOD-9604 was developed at Monash University in Australia and has been studied in both animal and clinical models for metabolic research since the 1990s.
Quick Specs
Every batch is independently tested for purity via HPLC-MS, endotoxins and heavy metals. Click here to view full COA documentation.
All products sold by Velora Peptides are for research use only by authorized research institutions and qualified researchers.